Journal: Nature Communications
Article Title: Prion protein conversion at two distinct cellular sites precedes fibrillisation
doi: 10.1038/s41467-023-43961-1
Figure Lengend Snippet: A – D Persistently prion-infected S7 cells were co-labelled with 6D11 and vesicular markers ( A ) Scg2, ( B ) Syn1 and ( C ) Vamp4 as well as with constitutively secreted Col4 ( D ). E SIM image of plasma membrane, triple-labelled with Syn1, 6D11 and 5B2. Magnified areas (a–c) are denoted by a dashed box in the first image. F Diagram of marker proteins used to map trafficking routes of 6D11-positive PrP d . G Levels of colocalisation between 6D11 and organelle/vesicular markers, expressed as Person correlation coefficients. Data from two independent experiments with at least 10 per protein are shown. For representative images and gene names we refer to Supplementary Fig. . H Neuronal depolarisation with 25 mM KCl led to rapid depletion of Syn1-positive vesicles in S7 cells. Cells were fixed at 5 min after incubation with KCl. Arrows in magnified areas denote synaptic vesicles. I Increased levels of co-labelled PrP d aggregates at the plasma membrane, following KCl-evoked depolarisation. Cells were fixed at 5 min after incubation with KCl. J Quantitative changes of co-labelled PrP d after depolarisation in dependence of the KCl concentration normalised to untreated cells from three independent experiments with at least 36 replicates per condition. For statistical analysis, ANOVA with Bonferroni correction for multiple comparisons was conducted. K Quantitative changes in surface PrP levels after KCl-evoked depolarisation in uninfected S7 versus prion-infected iS7 cells. Following fixation, cells were stained with anti-PrP antibody 8H4. Data from three independent experiments with at least 48 images per experiment were analysed. Data represent mean values ± SEM. Statistical significance was evaluated by Student’s t -test ( p < 0.01). Source data are provided as a Source Data file.
Article Snippet: Mouse monoclonal anti-PrP (8H4, Sigma, P0110), rat monoclonal Lamp1 (1D4B, Santa Cruz Biotechnology (SCB), sc-19992), mouse monoclonal anti-PrP (5B2, SCB, sc-47730, used at a 1:500 dilution), mouse monoclonal anti-PrP (AH6, SCB, sc-69896), mouse monoclonal anti-PrP (8B4, SCB, sc-47729), mouse monoclonal anti-Syp (7.2, Synaptic Systems, 101 011), rabbit polyclonal anti-Vamp4 (Synaptic Systems, 136 002), rabbit polyclonal anti-Chga (Synaptic Systems, 259 003), rabbit polyclonal anti-phospho FAK (Tyr925, Cell Signaling Technology, 3284), rabbit polyclonal anti-beta Cop (Thermo Fisher Scientific, PA1-061), rabbit polyclonal anti-Scg2 (Abcam, ab12241), mouse monoclonal anti-PrP (7D9, Abcam, ab14219), rabbit polyclonal anti Col4 (AbD Serotech, 2150-1470), rat monoclonal anti-CD29 (9EG7, BD Biosciences, 553715), mouse monoclonal anti-GM130 (35, BD Biosciences, 610822), mouse monoclonal anti-PrP (6D11, BioLegend, 808002), mouse monoclonal anti-PrP (Saf32, Cayman, 189720), rabbit monoclonal anti-PDI (C81H6, Cell Signaling Technology, 3501 S), rabbit monoclonal anti-Eea1 (C45B10, Cell Signaling Technology, 3288), rabbit polyclonal anti-Lc3a (Cell Signaling Technology, 4599), rabbit polyclonal anti-GFAP (DAKO, Z0334, used at a 1:10,000 dilution), Mouse monoclonal anti-PrP (3F4, Merck, MAB1562), mouse monoclonal anti-PrP (MAB5424, Merck, MAB5424), mouse monoclonal anti-myc, AF 488-conjugated (9E10, Merck, 16-308), rabbit polyclonal anti-Syp1 (Millipore, AB1543), mouse monoclonal anti-Snap25 (SP14, Millipore, MAB331), rabbit polyclonal anti-Gorasp2 (Grasp55) (Proteintech, 10598-1-AP), mouse monoclonal anti-PrP (AG4, TSE Resources Centre, TSE RC, RC 059), mouse monoclonal anti-PrP (GE8, TSE Resources Centre, TSE RC, RC 061), ICSM18 and ICSM35 (UCL Institute of Prion Diseases), chicken polyclonal anti-Map2 (Abcam, ab5392).
Techniques: Infection, Membrane, Marker, Incubation, Concentration Assay, Staining